Turbare Manufacturing is recalling approximately 1,147 syringes of Avastin (bevacizumab) 1.25 mg/0.05 mL in 0.25 mL Syringes used for eye injections. The recall was initiated because of a quality control process deviation that resulted in a lack of assurance of the product's sterility. Because these syringes are intended for injection directly into the eye, sterility is critical for patient safety. Healthcare providers and clinics should stop using these syringes immediately and contact the manufacturer or their distributor to arrange for a return.
The use of a non-sterile injectable drug in the eye poses a significant risk of serious infection, such as endophthalmitis. Such infections can lead to severe ocular complications, including permanent vision loss or blindness.
Office Use Only - Not for Resale - Single Use. Repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.